Press Contacts: Erik Cummins, Matt Hyams, Olivia Thomas
Reflective of Pillsbury’s strong Digital Health and Israel practices, the firm is partnering with leading Israeli technology investor Arieli Capital and Connecticut’s premier health & wellness destination Bridge Healing Arts Center to present a second round of the companies’ successful Well4Tech bootcamp. Pillsbury attorney Nathan Renov (Intellectual Property) will again serve as a mentor for the program, sharing his firsthand knowledge and insights with the company founders chosen to take part.
Well4Tech is a four-day program affording participants access to more than 160 sessions with investors and industry leaders that focuses on three critical areas of startup support: 1) market expansion, 2) partners and client lead generation and 3) capital exposure. The initial Well4Tech program, which occurred in May 2022, included a total of six companies that are now collectively valued over $42 million.
Companies interested in applying to be a part of Well4Tech’s second cohort can apply before September 5 by visiting www.Well4Tech.com.
Pillsbury’s Digital Health team works closely with companies trying to achieve a simple but profound goal—the radical improvement of health care outcomes for everyone. From big data, artificial intelligence, blockchains and wearables to telehealth, personalized medicine and digital therapeutics, our lawyers assist with all the technologies and the full spectrum of legal, business and regulatory issues impacting this swiftly evolving and transformative sector.
Additionally, Pillsbury’s Israel Practice team works closely with companies and investors doing business in Israel, as well as Israeli companies with commercial interests in other global markets. Leveraging trusted relationships with top Israeli firms and other local professional service providers, Pillsbury helps clients successfully conclude sophisticated cross-border transactions including financings, mergers and acquisitions, joint ventures and technology agreements; navigate U.S. regulatory and public policy matters, including investment and trade strategies; and develop compliance programs that mitigate risk across their global operations.